Ihre Region: Deutschland

Referenzen

In absteigender Reihenfolge

1476-1500 von 2039

Produkte Transfektion
Kostenlose Testsamples

Anwendungshinweise:

Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.

Keine Referenz? > Allgemeine Auswahlhilfe

Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.



CELL TYPE DESCRIPTION OF CELL TYPE CAT.NO. SPECIES ORIGIN OF CELLS COMMON CELL TYPE GROWTH PROPERTIES NUCLEIC ACID / DELIVERED MOLECULE APPLICATION PRODUCT REFERENCE TYPE BIBLIOGRAPHIC DATA PDF LINK

MCF-7

Human breast adenocarcinoma cell line ATCC HTB-22 Human breast cell line adherent plasmid stable transfection Metafectene EASY publication K. Haagenson, Dissertation, 2013, Wayne State University Link

MCF-7

Human breast adenocarcinoma cell line ATCC HTB-22 Human breast cell line adherent GNP-DNA Metafectene publication S. E. Feky et al., ESMO Open, 2018, doi.org/10.1136/esmoopen-2018-EACR25.463 Link

MCF-7

Human breast adenocarcinoma cell line ATCC HTB-22 Human breast cell line adherent plasmid K2 Transfection System publication A. Hermawan, Ludwig-Maximilians-Universität München Link

MCF-7

Human breast adenocarcinoma cell line ATCC HTB-22 Human breast cell line adherent miRNA K2 Transfection System publication B. Ljepoja et al., Breast, 2019, 43, 31e38, https://doi.org/10.1016/j.breast.2018.10.007 Link

MCF-7

Human breast adenocarcinoma cell line ATCC HTB-22 Human breast cell line adherent plasmid Metafectene publication M. R. Graf et al., J. of Cancer Ther. & Res., 2012, doi: 10.7243/2049-7962-1-25 Link

MCF-7

Human breast adenocarcinoma cell line ATCC HTB-22 Human breast cell line adherent siRNA RNA-Interference K2 Transfection System publication B. Ljepoja et al., PLoS ONE, 2019, 14(11): e0224314, doi.org/10.1371/journal.pone.0224314 Link

MCF-7

Human breast adenocarcinoma cell line ATCC HTB-22 Human breast cell line adherent siRNA RNA-Interference Metafectene publication X. Ming et al., Am. Ass. for Cancer Res., 2018, DOI: 10.1158/1541-7786.MCR-18-0070 Link

MCF-7

Human breast adenocarcinoma cell line ATCC HTB-22 Human breast cell line adherent siRNA RNA-Interference K2 Transfection System application note

MCF-7

Human breast adenocarcinoma cell line ATCC HTB-22 Human breast cell line adherent miRNA K2 Transfection System publication B. Ljepoja, Dissertation, 2019, Ludwig-Maximilians-Universität München Link

MCF-7

Human breast adenocarcinoma cell line ATCC HTB-22 Human breast cell line adherent siRNA RNA-Interference Metafectene PRO publication D. V. Sorokin et al., Cell Technologies in Biology and Medicine, 2016, 4: 555-559; DOI 10.1007/s10517-016-3217-5

MCF-7

Human breast adenocarcinoma cell line ATCC HTB-22 Human breast cell line adherent siRNA RNA-Interference Metafectene publication A. Benito et al., Oncotarget, 2017, 8 (63): 106693-106706 Link

MCF-7

Human breast adenocarcinoma cell line ATCC HTB-22 Human breast cell line adherent plasmid K2 Transfection System publication B. Ljepoja et al.,The Breast, 2019, 43: 31-38, doi.org/10.1016/j.breast.2018.10.007 Link

MCF-7

Human breast adenocarcinoma cell line ATCC HTB-22 Human breast cell line adherent plasmid Metafectene PRO publication Z. Mbita, Dissertation, 2012, University of the Witwatersrand Link

MCF-7

Human breast adenocarcinoma cell line ATCC HTB-22 Human breast cell line adherent plasmid Metafectene PRO publication V. Vella et al., Endocrine-Related Cancer, 2019, 26: 197–214, doi.org/10.1530/ERC-18-0310

MCF-7

Human breast adenocarcinoma cell line ATCC HTB-22 Human breast cell line adherent plasmid K2 Transfection System publication C. Actis et al., Cancers, 2021, 13: 1252, doi.org/10.3390/cancers13061252 Link

MCF-7

Human breast adenocarcinoma cell line ATCC HTB-22 Human breast cell line adherent siRNA RNA-Interference Metafectene PRO publication C. Thirukkumaran et al., PLOSONE 2017, DOI:10.1371/journal.pone.0168233 Link

MCF-7

Human breast adenocarcinoma cell line ATCC HTB-22 Human breast cell line adherent plasmid Metafectene publication A. M. Scherbakov et al., Frontiers in Pharmacology, 2018, 8:979, doi: 10.3389/fphar.2017.00979 Link

MCF-7

Human breast adenocarcinoma cell line ATCC HTB-22 Human breast cell line adherent plasmid Metafectene PRO publication M. S. Herrera, PhD Thesis, 2021, University of Alberta Link

MCF10A

Human breast fibrocystic disease cell line ATCC CRL-10317 Human breast cell line adherent plasmid Metafectene publication M. P.V. Shekhar et al., Mol. Cancer Res., Oct 2006; 4: 729 - 745 Link

MCF10A

Human breast fibrocystic disease cell line ATCC CRL-10317 Human breast cell line adherent plasmid Metafectene PRO publication L. Qin et al., Cell Reports, 2015,13: 2056-2063; doi.org/10.1016/j.celrep.2015.11.015 Link

MCF10A

Human breast fibrocystic disease cell line ATCC CRL-10317 Human breast cell line adherent plasmid Metafectene publication M. P.V. Shekhar et al., Cancer Res., Mar 2008; 68: 1741 - 1750 Link

MCF10A

Human breast fibrocystic disease cell line ATCC CRL-10317 Human breast cell line adherent plasmid Metafectene publication E. Xu et al., Mol. Cancer Res., 2014, 12(3):359-369, DOI: 10.1158/1541-7786.MCR-13-0526 Link

MCF10A

Human breast fibrocystic disease cell line ATCC CRL-10317 Human breast cell line adherent plasmid Metafectene PRO publication H.-K. Lee, PhD Thesis, 2015, Seoul National University Link

MCF10A-Rad6B

Human breast fibrocystic disease cell line, stably expressing Rad6B Human breast cell line adherent plasmid RNA-Interference Metafectene publication M. P.V. Shekhar et al., Cancer Res., Mar 2008; 68: 1741 - 1750 Link

MCF7

Human breast fibrocystic disease cell line ATCC HTB-22 Human breast cell line adherent plasmid stable transfection K2 Transfection System publication B. Ljepoja, Dissertation, 2019, Ludwig-Maximilians-Universität München Link

In absteigender Reihenfolge

1476-1500 von 2039